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 The mitochondrial SIRT1 – PGC-
1  axis in podocyte injury 
 Shuichi  Tsuruoka 1 ,  Akira  Hiwatashi 1 ,  Joichi  Usui 1 and  
 Kunihiro  Yamagata 1 
 Dysfunction of mitochondria in podocytes is believed to be a trigger 
of injury and contributes to progressive glomerular sclerosis; however, 
the mechanisms had not been fully understood. Yuan  et al. report 
involvement of SIRT1 (a homolog of the life-extending gene  sir2 
in mammals) and PPAR-  coactivator 1  , a major regulator of oxidative 
metabolism, in mitochondria during podocyte injury. This information 
will be important in exploration of the mechanisms and future 
treatment of glomerular sclerosis. 
 Kidney International (2012)  82, 735 – 736.  doi: 10.1038/ki.2012.182 
 Th e podocyte is one of the components 
of the glomerular fi ltration barrier and 
serves to prevent filtration of protein 
from the blood. Th is cell is terminally dif-
ferentiated and highly specialized. Mature 
podocytes have limited ability to prolifer-
ate following injury, linked to high 
expression of the cyclin-dependent 
kinase inhibitors, which appear to be 
rate-limiting for podocytes to reenter 
the cell cycle. 1 Podocyte injury causes 
detachment of the cell from the barrier. 
Once podocytes have detached from the 
glomerular basement membrane (GBM), 
the exposed outer surface of the GBM 
adheres to the inner surface of the 
Bowman ’ s capsule, and a focal segmental 
glomerulosclerosis (FSGS) lesion is 
established. 1 This series of changes is 
commonly seen in various types of 
glomerular disease and causes progres-
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sion of chronic kidney disease. Th e mecha-
nisms of the injury of this cell are not 
fully understood; however, several mecha-
nisms, such as peroxisome proliferator-
activated receptor-  (PPAR-  )-mediated 
apoptosis and increase of reactive oxygen 
species, were reported in an animal model 
of puromycin aminonucleoside nephrosis 
with FSGS. 1 
 Mitochondria are essential intracellular 
organelles that have a major role in energy 
production by adenosine triphosphate 
(ATP) synthesis through oxidative phos-
phorylation. Each mitochondrion has its 
own DNA, which is the only extranuclear 
genome in eukaryotes. Mitochondrial 
DNA (mtDNA) is prone to oxidative 
stress, as it apparently lacks histone-like 
coverage and is localized closely to the 
inner mitochondrial membrane, a major 
site of reactive oxygen species in cells. 2 
Mitochondrial dysfunction causes various 
types of diseases, such as myopathy 
and encephalopathy. 3 With regard to the 
kidney, mitochondrial dysfunction was 
reported mainly in tubular cells. For exam-
ple, acute kidney injury by various toxins 
and hypoxia causes the dysfunction 
of mitochondria in proximal tubular 
cells. 1,4 Although FSGS developed in 
children with mitochondrial cytopathies, 5 
information about mitochondrial dys-
function in glomerular disease was still 
limited. In a rat model of puromycin 
aminonucleoside nephrosis with FSGS, 
reduction of mtDNA copy number in 
podocytes was reported. 2 Th erefore, podo-
cyte injury was triggered by mitochondrial 
dysfunction due to mtDNA depletion of 
the cell, which led to glomerular sclerosis, 
perhaps via an increase of oxidative stress 
and a relative shortage of ATP synthesis 
resulting from the energy demand of the 
podocyte; however, the mechanisms were 
not fully understood. 
 It was previously reported that PPAR-  
coactivator 1  (PGC-1  ), a transcriptional 
activator of PPAR-  , is a major regulator of 
mitochondrial oxidative metabolism, which 
specifi cally binds to the mitochondrial tran-
scription factor A (TFAM) promoter, a 
direct regulator of mtDNA replication in 
non-kidney cells. 1,6 It was also recently 
reported that SIRT1 (silent mating type 
information regulation 2 homolog 1, a 
homolog of the life-extending gene  sir2 in 
mammals) regulates PGC-1  activity and 
energy metabolism of mitochondria by 
its deacetylation in different tissues. 7 
With regard to the kidney, modifi cation 
of cisplatin-induced acute kidney injury 
by transgenic overexpression of SIRT1 in 
S1- and S2-segment proximal tubules 
was reported. 8 It was also reported that 
calorie restriction enhances cell adaptation 
to hypoxia through SIRT1-dependent 
mitochondrial autophagy in mouse renal 
tubules. 9 
 Yuan  et al. 10 (this issue) report several 
lines of evidence that the activation of 
the SIRT1 – PGC-1  axis in mitochondria 
ameliorates aldosterone-induced podo-
cyte injury  in vitro and  in vivo . They 
found that aldosterone suppressed 
SIRT1 – PGC-1  activation in the cultured 
podocytes. They further showed that 
overexpression of SIRT1 or PGC-1  inhi-
bited the aldosterone-induced mitochon-
drial dysfunction and podocyte injury. 
Resveratrol, an activator of SIRT1, pro-
tected mitochondrial function against 
podocyte injury in aldosterone-treated 
mice. Th e authors also showed that podo-
cyte injury by aldosterone was mediated 
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by mineralocorticoid receptor in the 
cell. This is the first study to identify 
mechanisms of mitochondrial dysfunc-
tion involving the SIRT1 – PGC-1  axis in 
podocytes during injury ( Figure 1 ), which 
will be important in the consideration of 
mechanisms of glomerular sclerosis in the 
future. 
 Although this paper is novel, the study 
has several limitations. Aldosterone-treated 
mice are not a frequently used model for 
FSGS. Indeed, patients with primary aldo-
steronism usually do not show severe pro-
teinuria and podocyte injury as patients 
with FSGS do; the main clinical problems 
of these patients are hypertension with 
hypokalemia and subsequent tubular dam-
age by the aldosterone-induced hypokale-
mia. 11 One study found aldosterone-induced 
proteinuria due to podocyte injury in high-
salt-fed mice, which occurred via upregula-
tion of mineralocorticoid receptor of the 
cell by the high-salt diet. 12 However, Yuan 
 et al. 10 did not use a high-salt diet. Th ere-
fore, further evaluation of the SIRT1 – PGC-
1  pathway in podocytes with other models 
that are much closer to human FSGS are 
needed to understand the mechanisms of 
the mitochondrial injury in this disease. 
Th e dose of aldosterone might need to be a 
little higher than that used for aldosterone-
induced injury in other organs. Finally, the 
importance of other regulatory molecules 
located upstream of PGC-1  after ATP 
depletion in other cells, such as AMP-acti-
vated protein kinase and calcium / calmo-
dulin-dependent protein kinase, 4 was not 
evaluated. Resolution of these problems 
will be important for the exploration of the 
mechanisms of glomerular sclerosis, which, 
in turn, is important to the investigation 
of the mechanisms and treatment of the 
progression of chronic kidney diseases. 
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 Figure 1  |  Schematic representation of the SIRT1 – PGC-1  axis in podocyte mitochondria in physiological conditions (top) and in injury 
(bottom). PGC-1  deacetylated by SIRT1, combined with NRF1 and NRF2, increases mitochondrial transcription factors; this is essential to 
maintain mitochondrial function. Stresses such as aldosterone suppress SIRT1 function and prevent the deacetylation, leading to mitochondrial 
dysfunction in podocytes and glomerular sclerosis. AC, acetylation; GBM, glomerular basement membrane; NAD   +   , nicotinamide adenine dinucleotide; 
NRF, nuclear respiratory factor; PGC-1  , peroxisome proliferator-activated receptor-  coactivator 1  ; SIRT1, silent mating type information 
regulation 2 homolog 1. 
